

Fundamental dimension Equity attribute | GSKLeader $50.59▼-1.21% Cap $101.4BP/E 15.8x QuantScore59/100 | AMGNPeer $424.94▼-1.75% Cap $229.7BP/E 26.2x QuantScore58/100 | AZNPeer $170.90▼-0.97% Cap $265.0BP/E 25.6x QuantScore59/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
75/100 |
96/100 |
73/100 |
Valuation Multiples, PEG & DCF upside | 98/100 | 85/100 | 80/100 |
Health Piotroski, Altman Z, leverage & liquidity | 42/100 | 32/100 | 50/100 |
Growth Revenue / earnings growth & margins | 49/100 | 59/100 | 56/100 |
Sentiment Analyst ratings, targets & revisions | 29/100 | 16/100 | 35/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 15.8x | 26.2x | 25.6x |
Forward P/E (next FY) | 14.0x | 18.4x | 16.7x |
EV / EBITDA (TTM) | 8.5x | 15.5x | 14.3x |
Price / Sales | 2.3x | 6.0x | 4.3x |
Price / Free Cash Flow | 13.2x | 22.6x | 31.5x |
PEG ratio | 0.37 | 0.83 | 1.09 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 8 / 9 | 8 / 9 | 8 / 9 |
Altman Z-Score | 2.10 (Grey) | 2.31 (Grey) | 3.45 (Safe) |
Total debt / equity | 1.03 | 4.90 | 0.64 |
Quick ratio | 0.5x | 1.1x | 0.7x |
Interest coverage | 11.4x | 4.7x | 8.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +4.1% | +9.9% | +8.6% |
Net income growth YoY | +122.0% | +88.5% | +45.8% |
Gross margin (TTM) | 73.3% | 72.7% | 79.3% |
Operating margin (FY) | 25.5% | 29.1% | 23.4% |
FCF margin (FY) | 17.8% | 22.0% | 14.8% |
5. Trailing price performancePrice change over period |
1M return | +2.1% | +10.2% | +5.0% |
3M return | +0.0% | +16.0% | +1.9% |
6M return | -8.8% | +19.6% | -10.8% |
Year to date | +3.5% | +29.8% | -2.3% |
1Y return | +11.4% | +40.1% | +1.9% |
3Y return | +41.8% | +51.4% | +38.6% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $120.39 +138.0% upside | $860.35 +102.5% upside | $483.37 +182.8% upside |
Wall Street consensus target | $60.00 +18.6% · range $60.00–$60.00 | $401.16 -5.6% · range $230.00–$500.00 | $186.67 +9.2% · range $158.00–$216.00 |
Consensus stance | 31% Buy55% Hold14% Sell | 54% Buy39% Hold7% Sell | 49% Buy37% Hold15% Sell |